At CES 2025, L’Oréal Groupe presented a major innovation in skincare : L’Oréal Cell BioPrint, which will be launched in Asia as early as 2025.
The global skincare market is booming, and is expected to reach $125 billion by 2024. It is driven by consumers who are increasingly concerned about product efficacy and personalization.
The new L’Oréal Cell BioPrint device is a response to this growing demand for made-to-measure skincare. Thanks to years of advanced biomarker research, L’Oréal has been able to identify key elements capable of revealing skin health and its aging mechanisms.
© L’Oréal
L’Oréal Cell BioPrint is based on Longevity Integrative Science, a revolutionary approach developed by L’Oréal, which explores the links between the body’s biological mechanisms and skin appearance. This analysis system is the fruit of an exclusive partnership with South Korean startup NanoEnTek, which specializes in microfluidic technologies.
To continue reading this article, subscribe or log in to your account
Discover our plans
- Every day, keep up to date with the latest business news from the world of luxury.
- Receive the essential luxury business news by email every week
- Access all our events
- The Luxury Journals and Luxus Magazine in print and digital versions
Subscribe for 1€
Become an active member of the community of luxury leaders.
Read also > L’Oréal acquires skin microbiome specialist Lactobio
Featured photo : © L’Oréal
